Denis Migliorini, MD is a Physician-Scientist and Associate Professor at the University of Geneva Faculty of Medicine since January 2026. An expert in neuro-onco-immunology, he treats patients with ...
With clinical data beginning to emerge, big pharma is signaling its belief that in vivo CAR generation is the next immunotherapy breakthrough.
Nordot on MSN
Japan approves first iPS stem cell treatments – why Parkinson's and heart failure patients are watching anxiously
On 6 March 2026, Japan approved the world’s first iPS stem cell treatments for Parkinson’s and severe heart failure. Could ...
Researchers engineered immune cells that protect insulin-producing cell transplants, bringing scientists closer to a cure for type 1 diabetes.
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel mechanisms of the metabolic-immune interaction that ...
A new study reports that GLP-1 semaglutide medications may help reverse the effects of osteoarthritis in the joints by ...
The International Society for Stem Cell Research (ISSCR) is pleased to announce that Alexander Meissner, Director at the Max Planck Institute for Molecular Genetics, Germany, has been named the ...
The International Society for Stem Cell Research (ISSCR) is pleased to announce Stem Cell COREdinates and CorEUstem as the ...
A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center report that ...
Tumor metabolomics is an emerging field focused on understanding the metabolic alterations that occur in tumor cells and their surrounding microenvironment. These changes are essential to support the ...
Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...
Morning Overview on MSN
Scientists say they can restore 'young' memories by rewiring your brain
Researchers have used gene therapy to partially reprogram the brain cells that store memories in aging mice, reversing signs of cellular decline and restoring learning ability. The technique, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results